期刊文献+

Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 被引量:5

The Correlation between the Up-regulation of Hsp90 and Drug Resistance to Cisplatin in Lung Cancer Cell Line
下载PDF
导出
摘要 背景与目的热休克蛋白(heatshockprotein,Hsp)90是Hsps家族中的重要成员,其高表达与肿瘤的发生、发展及化疗耐药密切相关。本研究旨在探讨替普瑞酮(geranylgeranylacetone,GGA)作用下人肺癌细胞SPCA-1及H446中Hsp90的表达水平变化及与肺癌细胞对顺铂化疗耐药的相关性。方法将细胞分成实验组与对照组,分别用含有不同浓度(0μM,10μM,50μM,100μM,500μM,1,000μM)的诱导剂GGA处理6h。采用免疫荧光细胞化学及West-ernblot方法检测各组细胞中Hsp90在蛋白水平的表达;应用MTT法测定细胞在化疗药物顺铂作用下生存率,并分析Hsp90的表达在两种肺癌细胞对顺铂耐药中的作用。结果 SPCA-1及H446实验组细胞中Hsp90的表达水平均明显高于相应的对照组细胞,且与GGA具有一定的浓度依赖性。MTT显示两种实验组细胞对顺铂的生存率均明显高于相应的对照组细胞,亦呈一定的GGA浓度依赖性。结论 GGA可以诱导人肺癌细胞SPCA-1及H446中的Hsp90的表达上调,且其表达水平都与GGA具有一定的浓度依赖性。Hsp90高表达的细胞对顺铂的生存率明显高于低表达的细胞,表明Hsp90的表达上调与肺癌细胞对顺铂的耐药有一定的相关性。 Background and objective Hsp90 is a major molecular chaperone, which overexpression is involved in oncogenesis, development and drug resistance in many human cancers. The aim of this study is to investigate the relationship between the GGA-induced overexpression of Hsp90 and chemoresistance to Cisplatin in SPCA-1 and H446 cell line. Methods The protein expressions of Hsp90 induced by GGA at different concentrations were analyzed by Immunofluorescence and Western blotting. Cells survival to Cisplatin was determined using the MTT assays. The effect of Hsp90 expression on the drug resistance to Cisplatin in two Cell Lines was analyzed. Results Compared with the respective control cells, Hsp90 expressions in both experimental cell lines were up-regulated obviously, exhibiting a dose-dependent manner to GGA. MTT assays revealed that the IC50s of cisplatin also showed a substantial elevation for the experimental cells of SPCA-1 and H446, and this elevation was also associated with GGA concerntration. Conclusion GGA is effective for the induction of Hsp90 in the SPCA-1 and H446 cell line. Up-regulated Hsp90 is associated with the chemoresistance to Cisplatin in SPCA-1and H446 cells.
出处 《中国肺癌杂志》 CAS 2011年第6期472-477,共6页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 HSP90 GGA 化疗耐药 Lung neoplasms Hsp90 GGA Drug resistance
  • 相关文献

参考文献29

  • 1Tomida A, Tsuruo T. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des, 1999, 14(2): 169-177.
  • 2Jolly C, Morimoto RI. Role of the heat shock response and molecular Chap- erones in oncogenesis and cell death. J Natl Cancer Inst, 2000, 92(19): 1.564-1572.
  • 3Hanahan D, Weinberg RA. The hallmarks of cancer. Cell, 2000, 100(1): 57-70.
  • 4Gress TM, Muller-Pinasch F, Weber C, et al. Differential expression of heat shock proteins in human pancreatic carcinoma. Cancer Res, 1994, 54(2): 547-551.
  • 5Yano M, Naito Z, Tanaka S, et al. Expression and roles of heat shock proteins in human breast cancer.Jpn J Cancer Res, 1996, 87(9): 908-915.
  • 6刘宪玲,叶苓,王建波,樊代明.热休克蛋白HSP90β在人胃癌组织及耐药细胞系中的表达[J].第四军医大学学报,2000,21(2):131-134. 被引量:19
  • 7陈奕,丁健.热休克蛋白90——癌症治疗的新靶点[J].癌症,2004,23(8):968-974. 被引量:17
  • 8Sreedhar AS, Soti C, Csermely E Inhibition of Hsp90: a new strategy for in- hibiting protein kinases. Biochim Biophys Acta, 2004, 1697( 1-2): 233-242.
  • 9Endo S, Hiramatsu N, Hayakawa K, et al. Geranylgeranylacetone, an inducer of the 70-kDa heat shock protein (HSPT0), elicits unfolded protein response and coordinates cellular fate independently of HSP70. Mol Pharmacot, 2007, 72(5): 1337-1348.
  • 10Basso AD, Solit DB, Chiosis G, et al. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of lisp90 function. Biol Chem, 2002, 277(42): 39858-39866.

二级参考文献96

  • 1Kane LP et al. Curr Biol, 1999, 9:601.
  • 2Sato Set al. Proc Natl Acad Sci USA, 2000, 97:10832.
  • 3Fujita Net al. J Biol Chem, 2002, 277:10346.
  • 4Basso AD et al. J Biol Chem, 2002, 277: 39858.
  • 5Solit DB et al. Cancer Res, 2003, 63:2139.
  • 6Yu X et al. J Natl Cancer Inst, 2002, 94: 504.
  • 7Grammatikakis N et al. Mol Cell Biol, 1999, 19:1661.
  • 8Song J et al. Nat Cell Biol, 2001, 3:276.
  • 9Neckers L. Trends Mol Med, 2002, 8:S55.
  • 10Young JC et al. J Cell Biol, 2001, 154:267.

共引文献47

同被引文献32

  • 1闫天中,靳风烁,江军,李彦锋,李黔生.GR、Hsp90表达与前列腺癌生物学行为的关系[J].医学临床研究,2004,21(11):1298-1301. 被引量:1
  • 2赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 3Davidson JD, Ma L, Flagella M, et al . An increase in the ex- pression of ribonucleotide reductase large subunit 1 is associ- ated with gemcitabine resistance in non-small cell lung cancercell lines[J]. Cancer Res ,2004, 64(1) : 3761-3768.
  • 4Laing RE, Walte MA, Campbell DO, et al . Noninvasive pre- diction of tumor responses to gemcitabine using positron e- mission tomography[J]. PNAS ,2009,106(8) : 2847-2852.
  • 5Stewart DJ. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer[J]. Crit Rev Oncol Hematol , 2010,5 (3) : 173-234.
  • 6Lu X, Xiao L, Wang L, et al . Hsp90 inhibitors and drug re- sistance in cancer.- The potential benefits of combination ther- apies of Hspg0 inhibitors and other anti-cancer drugs [J]. Biochem Pharrnacol ,2012,83(8) : 995-1004.
  • 7Ko JC, Chen HJ, Huang YC, et al. HSP90 inhibition in- duces eytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells [J]. Regul Toxicol Pharmacol ,2012,6(3): 415-424.
  • 8Rodina A, Vilenchik M, Moulick K, et al . Selective com- pounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer[J]. Nat Chern Biol ,2007,3(8):498 - 507.
  • 9MacLean MJ, Llordella MM, Bot N, et al . A yeast-based as- say reveals a functional defect of the Q488H polymorphism in human Hspg0a[J]. Biochem Biophys Res Commun , 2005, 337(1) : 133-137.
  • 10Dong D,Ni M,Li J, et al . Critical role of the stress chaperone GRP78 / BiP in tumor proliferation, survival, and tumor an- giongenesis in transgene-indueed mammary tumor develop- ment[J]. Cancer Res ,2008,68(2) : 498 -505.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部